Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Medifast
(NYSE:MED)
Intraday
$33.50
-0.07
[-0.21%]
After-Hours
$33.50
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$33.50
-0.07
[-0.21%]
At close: Apr 25
$33.50
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 Earnings in 3 days from now on Mon Apr 29th, after the market close
Conference call scheduled in 3 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Medifast Stock (NYSE:MED)
Medifast Stock (NYSE: MED)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 01, 2024
(MED) - Analyzing Medifast's Short Interest
Benzinga Insights
-
Apr 1, 2024, 9:00AM
Wednesday, March 06, 2024
Navigating Challenges and Investor Rewards: Nu Skin Enterprises Ensures Steady Distribution amidst Changing Profits
Benzinga Insights
-
Mar 6, 2024, 10:05AM
Wednesday, February 21, 2024
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 21, 2024, 1:50PM
DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $40
Benzinga Newsdesk
-
Feb 21, 2024, 1:22PM
Medifast shares are trading lower after the company issued weak guidance.
Benzinga Newsdesk
-
Feb 21, 2024, 8:38AM
Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
Feb 21, 2024, 5:09AM
Tuesday, February 20, 2024
Medifast shares are trading lower after the company issued weak guidance.
Benzinga Newsdesk
-
Feb 20, 2024, 5:04PM
MEDIFAST INC Sees Q1 2024 EPS $0.25-$0.95 Vs $1.50 Est.l Revenue $155M-$175M Vs $205.786M Est.
Benzinga Newsdesk
-
Feb 20, 2024, 4:42PM
Recap: Medifast Q4 Earnings
Benzinga Insights
-
Feb 20, 2024, 4:10PM
Medifast Q4 2023 Adj EPS $1.09 Beats $0.96 Estimate, Sales $191.01M Beat $184.15M Estimate
Benzinga Newsdesk
-
Feb 20, 2024, 4:08PM
Earnings Scheduled For February 20, 2024
Benzinga Insights
-
Feb 20, 2024, 6:52AM
Monday, February 19, 2024
A Preview Of Medifast's Earnings
Benzinga Insights
-
Feb 19, 2024, 1:01PM
Tuesday, February 13, 2024
Overview Of Value Stocks In The Consumer Cyclical Sector
Benzinga Insights
-
Feb 13, 2024, 9:43AM
Friday, February 02, 2024
Here's How Much You Would Have Made Owning Medifast Stock In The Last 15 Years
Benzinga Insights
-
Feb 2, 2024, 1:30PM
Wednesday, December 13, 2023
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Dec 13, 2023, 1:40PM
Why Is Wellness Company Medifast Stock Trading Lower Today?
Vandana Singh
-
Dec 13, 2023, 11:11AM
Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
-
Dec 13, 2023, 11:03AM
LifeMD And Medifast Partner To Offer Transformative Weight Management Solution
Benzinga Newsdesk
-
Dec 13, 2023, 6:03AM
Monday, November 06, 2023
Medifast Sees FY23 EPS $8.65-$9.55 Vs $8.52 Est.; Revenue $1.05B-$1.07B Vs $1.09B Est.; Guidance Assumes A 20.5%-21.5% Effective Tax Rate
Benzinga Newsdesk
-
Nov 6, 2023, 4:35PM
Medifast Q3 2023 Adj EPS $2.12 Beats $1.06 Estimate, Sales $235.87M Beat $232.10M Estimate
Benzinga Newsdesk
-
Nov 6, 2023, 4:18PM
Earnings Scheduled For November 6, 2023
Benzinga Insights
-
Nov 6, 2023, 8:24AM
Friday, November 03, 2023
Preview: Medifast's Earnings
Benzinga Insights
-
Nov 3, 2023, 12:01PM
Tuesday, October 17, 2023
5 Value Stocks In The Consumer Cyclical Sector
Benzinga Insights
-
Oct 17, 2023, 10:43AM
Friday, October 13, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
Benzinga Insights
-
Oct 13, 2023, 11:00AM
Stephens & Co. Initiates Coverage On Medifast with Equal-Weight Rating, Announces Price Target of $82
Benzinga Newsdesk
-
Oct 13, 2023, 5:00AM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 29, 2023, 2:09PM
Friday, September 22, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Risk Off Stocks Delivering High-Dividend Yields
Lisa Levin
-
Sep 22, 2023, 7:36AM
Wednesday, September 13, 2023
Friday Is Your Last Chance To Buy Medifast Before The Dividend Payout
Benzinga Insights
-
Sep 13, 2023, 10:45AM
Thursday, August 17, 2023
Medifast Insider Trades Send a Signal
Benzinga Insights
-
Aug 17, 2023, 11:04AM
Electronic Arts, Tractor Supply And 2 Other Stocks Insiders Are Selling
Lisa Levin
-
Aug 17, 2023, 8:22AM
Tuesday, August 15, 2023
A Look Into Consumer Cyclical Sector Value Stocks
Benzinga Insights
-
Aug 15, 2023, 10:43AM
Friday, August 11, 2023
Director of Medifast Purchased $72K In Stock
Benzinga Insights
-
Aug 11, 2023, 11:02AM
Tuesday, August 08, 2023
DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $80
Benzinga Newsdesk
-
Aug 8, 2023, 12:24PM
Monday, August 07, 2023
Medifast Expects Q3 Revenue Of $220M-$240M, EPS Of $0.71-$1.32
Benzinga Newsdesk
-
Aug 7, 2023, 4:39PM
Medifast Q2 EPS $2.77 Beats $1.44 Estimate, Sales $296.19M Beat $253.47M Estimate
Benzinga Newsdesk
-
Aug 7, 2023, 4:09PM
Earnings Scheduled For August 7, 2023
Benzinga Insights
-
Aug 7, 2023, 4:12AM
Friday, August 04, 2023
Medifast's Earnings: A Preview
Benzinga Insights
-
Aug 4, 2023, 12:01PM
Monday, July 31, 2023
DA Davidson Maintains Neutral on Medifast, Raises Price Target to $93
Benzinga Newsdesk
-
Jul 31, 2023, 12:14PM
Thursday, July 27, 2023
Medifast Expands Into $30B Sports Nutrition Category With OPTAVIA ACTIVE
Happy Mohamed
-
Jul 27, 2023, 5:17PM
Monday, July 17, 2023
Medifast: Transforming Lives And Reshaping The Health & Wellness Industry
Ernest Dela Aglanu
-
Sponsored
Wednesday, June 21, 2023
Medifast's Ex-Dividend Date Is Monday, Here's What You Need To Know
Benzinga Insights
-
Jun 21, 2023, 10:45AM
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 5% Dividend Yields
Lisa Levin
-
Jun 21, 2023, 9:07AM
Monday, June 05, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields
Lisa Levin
-
Jun 5, 2023, 9:09AM
Thursday, June 01, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jun 1, 2023, 12:59PM
Wednesday, May 31, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
May 31, 2023, 1:04PM
Tuesday, May 30, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
May 30, 2023, 2:13PM
Thursday, May 04, 2023
Check Out 3 High-Yielding Dividend Stocks In Consumer Staples Sector From Wall Street's Most Accurate Analysts
Lisa Levin
-
May 4, 2023, 9:06AM
Wednesday, May 03, 2023
Jenny Craig Loses All Its Weight, Confirms Closure After 40 Years: Who Benefits?
AJ Fabino
-
May 3, 2023, 11:30AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch